Hypocholesterolemic effect of ascorbic acid in maturity-onset diabetes mellitus. 1978

E Ginter, and B Zdichynec, and O Holzerová, and E Tichá, and R Kobza, and M Koziaková, and O Cerná, and L Ozdín, and F Hrubá, and V Nováková, and E Sasko, and M Gaher

A significantly lower vitamin C concentration has been found in the blood and particularly in the leukocytes of hypercholesterolemic diabetic patients than of healthy blood donors. Ascorbic acid administered in a dose of 500 mg per day for 12 months to metabolically stabilized hypercholesterolemic subjects with maturity-onset diabetes mellitus (diabetic diet without insulin or diabetic drugs) brought about a striking decline of cholesterolemia and a moderate decline of triglyceridemia. The serum lipid level in the control group given placebo remained unaltered. A daily administration of 500 mg of ascorbic acid for six months failed to affect the fasting level of serum immunoreactive insulin. It is assumed that the long-term administration of ascorbic acid to maturity-onset diabetics removed the tissue ascorbate deficiency and improved the liver ability to compensate the increased endogenous synthesis of cholesterol by its enhanced transformation to bile acids.

UI MeSH Term Description Entries
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol

Related Publications

E Ginter, and B Zdichynec, and O Holzerová, and E Tichá, and R Kobza, and M Koziaková, and O Cerná, and L Ozdín, and F Hrubá, and V Nováková, and E Sasko, and M Gaher
November 1976, JAMA,
E Ginter, and B Zdichynec, and O Holzerová, and E Tichá, and R Kobza, and M Koziaková, and O Cerná, and L Ozdín, and F Hrubá, and V Nováková, and E Sasko, and M Gaher
June 1976, JAMA,
E Ginter, and B Zdichynec, and O Holzerová, and E Tichá, and R Kobza, and M Koziaková, and O Cerná, and L Ozdín, and F Hrubá, and V Nováková, and E Sasko, and M Gaher
August 1967, Lancet (London, England),
E Ginter, and B Zdichynec, and O Holzerová, and E Tichá, and R Kobza, and M Koziaková, and O Cerná, and L Ozdín, and F Hrubá, and V Nováková, and E Sasko, and M Gaher
January 1973, Journal of the National Medical Association,
E Ginter, and B Zdichynec, and O Holzerová, and E Tichá, and R Kobza, and M Koziaková, and O Cerná, and L Ozdín, and F Hrubá, and V Nováková, and E Sasko, and M Gaher
March 1981, Journal of the Indian Medical Association,
E Ginter, and B Zdichynec, and O Holzerová, and E Tichá, and R Kobza, and M Koziaková, and O Cerná, and L Ozdín, and F Hrubá, and V Nováková, and E Sasko, and M Gaher
January 1979, Current medical research and opinion,
E Ginter, and B Zdichynec, and O Holzerová, and E Tichá, and R Kobza, and M Koziaková, and O Cerná, and L Ozdín, and F Hrubá, and V Nováková, and E Sasko, and M Gaher
November 1965, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
E Ginter, and B Zdichynec, and O Holzerová, and E Tichá, and R Kobza, and M Koziaková, and O Cerná, and L Ozdín, and F Hrubá, and V Nováková, and E Sasko, and M Gaher
January 1967, The New Zealand medical journal,
E Ginter, and B Zdichynec, and O Holzerová, and E Tichá, and R Kobza, and M Koziaková, and O Cerná, and L Ozdín, and F Hrubá, and V Nováková, and E Sasko, and M Gaher
October 1965, Annals of the New York Academy of Sciences,
E Ginter, and B Zdichynec, and O Holzerová, and E Tichá, and R Kobza, and M Koziaková, and O Cerná, and L Ozdín, and F Hrubá, and V Nováková, and E Sasko, and M Gaher
September 1972, British medical journal,
Copied contents to your clipboard!